BD MAX Extended Enteric Bacterial Panel, BD MAX System

Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System

BECTON, DICKINSON AND COMPANY

The following data is part of a premarket notification filed by Becton, Dickinson And Company with the FDA for Bd Max Extended Enteric Bacterial Panel, Bd Max System.

Pre-market Notification Details

Device IDK170308
510k NumberK170308
Device Name:BD MAX Extended Enteric Bacterial Panel, BD MAX System
ClassificationGastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System
Applicant BECTON, DICKINSON AND COMPANY 7 LOVETON CIRCLE Sparks,  MD  21152
ContactLaura Stewart
CorrespondentLaura Stewart
BECTON, DICKINSON AND COMPANY 7 LOVETON CIRCLE Sparks,  MD  21152
Product CodePCH  
CFR Regulation Number866.3990 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-02-01
Decision Date2017-05-02
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00382904438128 K170308 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.